Egeberg, Alexander http://orcid.org/0000-0001-8257-1816
Fowler, Joseph F. Jr.
Gislason, Gunnar H.
Thyssen, Jacob P.
Article History
First Online: 1 August 2016
Compliance with Ethical Standards
:
: Drs. Egeberg and Gislason had full access to all of the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis. Study concept and design: Alexander Egeberg and Jacob Thyssen. Acquisition, analysis, and interpretation of data: Alexander Egeberg, Gunnar Gislason, and Jacob Thyssen. Drafting of the manuscript: Alexander Egeberg and Jacob Thyssen. Critical revision of the manuscript for important intellectual content: Alexander Egeberg, Joseph Fowler, Gunnar Gislason, and Jacob Thyssen. Statistical analysis: Alexander Egeberg and Gunnar Gislason. Obtained funding: Alexander Egeberg. Administrative, technical, or material support: Alexander Egeberg, Gunnar Gislason, and Jacob Thyssen. Study supervision: Alexander Egeberg, Gunnar Gislason, and Jacob Thyssen.
: Dr. Egeberg has received research funding and/or consultancy honoraria from Pfizer and Eli Lilly. Dr. Gislason is supported by an unrestricted research scholarship from the Novo Nordisk Foundation, and reports research grants from Pfizer, Bristol–Myers Squibb, AstraZeneca, Bayer and Boehringer Ingelheim. Dr. Thyssen is supported by an unrestricted grant from the Lundbeck foundation, and has received consultancy and/or speaker honoraria from Galderma and MEDA. Dr Fowler has no conflicts of interest to declare.
: No funding was received for the conduct of this study or the preparation of the manuscript.
: The study was approved by the Danish Data Protection agency (ref. 2007-58-0015, int. ref. GEH-2014-018, I-suite 02736), and, in Denmark, register studies do not require approval from an ethical committee.